Therapeutic Effects of Tofacitinib on Pristane-Induced Murine Lupus

Jiayi LIN, Yaqin ZHANG, Meihua WANG, Yang ZHANG, Pin LI, Yingping CAO, Xuwei YANG

DOI: 10.46497/ArchRheumatol.2022.8252

Issue: Volume 37 - Issue 2 - June 2022
1386 2170

Impact of vitamin D level and supplementation on systemic lupus erythematosus patients during COVID-19 pandemic

Yasmin Adel, Mohamed Elgamal, Sherehan Adel Abdelsalam

DOI: 10.46497/ArchRheumatol.2022.8996

Issue: Volume 37 - Issue 2 - June 2022
1532 1784

Biological treatment in resistant adult-onset Still’s disease: A single-center, retrospective cohort study

Seda Çolak, Emre Tekgöz, Maghrur Mammadov, Muhammet Çınar, Sedat Yılmaz

DOI: 10.46497/ArchRheumatol.2022.8669

Issue: Volume 37 - Issue 1 - March 2022
1177 1116

A retrospective review of antiphospholipid syndrome from a South Asian country

Muhammad Zain Mushtaq, Syed Ahsan Ali, Zaibunnisa Sattar, Saad Bin Zafar Mahmood, Tazein Amber, Mehmood Riaz

DOI: 10.46497/ArchRheumatol.2022.8979

Issue: Volume 37 - Issue 1 - March 2022
1331 1291

Clinical study of factors associated with pregnancy outcomes in pregnant women with systemic lupus erythematosus in the southern China

Ke Zhang, Chunmei He, Qiaoting Deng, Wengen Li, Zhixiong Zhong, Jingyuan Hou

DOI: 10.46497/ArchRheumatol.2022.8870

Issue: Volume 37 - Issue 1 - March 2022
850 1547

Evaluation of personality disorders using the structured clinical interview for DSM-5 personality disorders, quality of life, and disease activity in patients with systemic lupus erythematosus

Yunus Durmaz, İlker İlhanlı, Pınar Durmaz

DOI: 10.46497/ArchRheumatol.2022.9002

Issue: Volume 37 - Issue 3 - September 2022
1148 1278

Pregnancy outcomes between pregnant systemic lupus erythematosus patients with clinical remission and those with low disease activity: A comparative study

Worawit Louthrenoo, Thananant Trongkamolthum, Nuntana Kasitanon, Antika Wongthanee

DOI: 10.46497/ArchRheumatol.2022.9140

Issue: Volume 37 - Issue 3 - September 2022
1001 906

Transition readiness in adolescents with juvenile idiopathic arthritis and their parents: Our single-center experience

Dragana Lazarević, Stefan Đorđević, Dušica Novaković, Maja Zečević, Gordana Sušić

DOI: 10.46497/ArchRheumatol.2022.9219

Issue: Volume 37 - Issue 3 - September 2022
928 945

Dysregulation of complement factor H in juvenile-onset systemic lupus erythematosus patients

Eman Eissa, Botros Morcos, Dalia Dorgham, Naglaa Kholoussi

DOI: 10.46497/ArchRheumatol.2022.9217

Issue: Volume 37 - Issue 3 - September 2022
1095 984

Demographic, clinical, laboratory data, prognostic, and treatment features of patients with antisynthetase syndrome: An international, two-center cohort study

Lila Morena Bueno Da Silva, Upendra Rathore, Vikas Agarwal, Latika Gupta, Samuel Katsuyuki Shinjo

DOI: 10.46497/ArchRheumatol.2022.9108

Issue: Volume 37 - Issue 3 - September 2022
1127 849

Efficacy of anakinra treatment in pediatric rheumatic diseases: Our single-center experience

Ferhat Demir, Eda Gürler, Betül Sözeri

DOI: 10.46497/ArchRheumatol.2022.8998

Issue: Volume 37 - Issue 3 - September 2022
1261 1046

The effects of glucocorticoid treatment on cardiovascular system in patients with systemic lupus erythematosus

Dominika Blachut, Brygida Przywara-Chowaniec, Jan Harpula, Andrzej Tomasik, Ewa Nowalany-Kozielska, Beata Morawiec

DOI: 10.46497/ArchRheumatol.2022.9255

Issue: Volume 37 - Issue 4 - December 2022
958 1131

MT-CO1 expression in nine organs and tissues of different-aged MRL/lpr mice: Investigation of mitochondrial respiratory chain dysfunction at organ level in systemic lupus erythematosus pathogenesis

Xinglan Huang, Peng Yan, Xinghua Song, Suiying Zhang, Yuqiong Deng, Caifeng Huang, Xiaoqing Zhao, Sheng Liu, Xiping Cheng, Dongjiang Liao

DOI: 10.46497/ArchRheumatol.2022.9168

Issue: Volume 37 - Issue 4 - December 2022
1245 1325

The association of urinary plasmin level with renal involvement and disease flare among systemic lupus erythematosus patients

Rasha Fawzy, Mounir Serag, Amal Soliman, Sania Elwia, Samia Mojahed

DOI: 10.46497/ArchRheumatol.2022.9307

Issue: Volume 37 - Issue 4 - December 2022
958 882

The reliability of Juvenile Arthritis Magnetic Resonance Imaging Scoring system in the evaluation of the shoulder joint in juvenile idiopathic arthritis

Murugan Sudhakar, Shivani Deswal, Namrita Sachdev, Somdipa Pal, Tribhuvan Pal Yadav

DOI: 10.46497/ArchRheumatol.2022.9304

Issue: Volume 37 - Issue 4 - December 2022
851 851

Identification of a novel mutation in complement receptor 2 in Chinese familial systemic lupus erythematosus

Yuewu Tang, Yi Luo

DOI: 10.46497/ArchRheumatol.2022.9167

Issue: Volume 37 - Issue 4 - December 2022
943 972

Antinuclear antibody-negative systemic lupus erythematosus: How many patients and how to identify?

Hejun Li, Yiqing Zheng, Ling Chen, Shunping Lin

DOI: 10.46497/ArchRheumatol.2022.9366

Issue: Volume 37 - Issue 4 - December 2022
2105 1386

Evaluation of the anti-RANKL monoclonal antibody in rheumatoid arthritis rats

Dawei Lv, Xiaodong Zhao

DOI: 10.46497/ArchRheumatol.2023.9240

Issue: Volume 38 - Issue 1 - March 2023
827 911

Serum cystatin C and βeta-2 microglobulin as potential biomarkers in children with lupus nephritis

Eman Baraka, Nashwa Hashaad, Walid Abdelhalim, Gehan Elolemy

DOI: 10.46497/ArchRheumatol.2023.8520

Issue: Volume 38 - Issue 1 - March 2023
838 884

Pro-apoptotic Bax mRNA expression: A novel predictor for systemic lupus erythematosus disease flare-up

Rasha N Yousef, Abeer Ramadan, Eman Awadallah, Alshaimaa R Alnaggar, Noha M Khalil, Mervat E.Behiry, Asmaa Ali, Hesham Gamal El Dine

DOI: 10.46497/ArchRheumatol.2023.9448

Issue: Volume 38 - Issue 1 - March 2023
777 918